MedPath

A Comparative Study to see the effect of Jatiphala Lepa( Myristica fragrans ) & Arjun Twak Lepa (Terminalia arjuna)in the management of Melasma.

Phase 2
Conditions
Health Condition 1: L814- Other melanin hyperpigmentation
Registration Number
CTRI/2022/12/048415
Lead Sponsor
Dr Megha Champati Sawle
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with signs and symptoms of vyanga- ruksha (dryness),khara, krushana varya(blackish edges),rakta varya(reddish edges), kandu (itching), daha(burning).

Exclusion Criteria

Vyanga along with kustharoga to be excluded.

Hyper pigmentation caused since birth.

Pregnant & lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To reduced hyperpigmentation of skin. To assess Skin Luster(Twakvaivarnta),Number of Lesion and Size of Lesion in Vyanga.Timepoint: 14 days study with 2 follow up (0,7,14)
Secondary Outcome Measures
NameTimeMethod
To observe adverse effect,if any.Timepoint: 14 days study with 2 follow up (0,7,14)
© Copyright 2025. All Rights Reserved by MedPath